Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (171-180 of 471) with videos related to

Pageof 48
Sort By:
Bone Marrow Transplantation|December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agentsIuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Haematologica|June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Leukemia Research|March 21, 2016
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myelomaWilson I Gonsalves, Michael M Timm, S Vincent Rajkumar, et al.
Bone Marrow Transplantation|November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosisIuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
Bone Marrow Transplantation|June 14, 2019
The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
American Journal of Hematology|September 28, 2010
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugsAngela Dispenzieri, David Dingli, Shaji K Kumar, et al.
British Journal of Haematology|May 1, 2018
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
American Journal of Hematology|November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosisMaria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Pageof 48

Showing results (171-180 of 471) with videos related to

Sort By:
Pageof 48
Bone Marrow Transplantation|December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agentsIuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Haematologica|June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Leukemia Research|March 21, 2016
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myelomaWilson I Gonsalves, Michael M Timm, S Vincent Rajkumar, et al.
Bone Marrow Transplantation|November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosisIuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
Bone Marrow Transplantation|June 14, 2019
The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
American Journal of Hematology|September 28, 2010
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugsAngela Dispenzieri, David Dingli, Shaji K Kumar, et al.
British Journal of Haematology|May 1, 2018
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
American Journal of Hematology|November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosisMaria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Pageof 48